Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.

Umesalma S, Kaemmer CA, Kohlmeyer JL, Letney B, Schab AM, Reilly JA, Sheehy RM, Hagen J, Tiwari N, Zhan F, Leidinger MR, O'Dorisio TM, Dillon J, Merrill RA, Meyerholz DK, Perl AL, Brown BJ, Braun TA, Scott AT, Ginader T, Taghiyev AF, Zamba GK, Howe JR, Strack S, Bellizzi AM, Narla G, Darbro BW, Quelle FW, Quelle DE.

J Clin Invest. 2019 Mar 4;130:1641-1653. doi: 10.1172/JCI123049. eCollection 2019 Mar 4.

2.

Calcium and P-glycoprotein independent synergism between schweinfurthins and verapamil.

Sheehy RM, Kuder CH, Bachman Z, Hohl RJ.

Cancer Biol Ther. 2015;16(8):1259-68. doi: 10.1080/15384047.2015.1056420. Epub 2015 Jun 5.

3.

Functional evaluation of a fluorescent schweinfurthin: mechanism of cytotoxicity and intracellular quantification.

Kuder CH, Sheehy RM, Neighbors JD, Wiemer DF, Hohl RJ.

Mol Pharmacol. 2012 Jul;82(1):9-16. doi: 10.1124/mol.111.077107. Epub 2012 Mar 29.

4.

Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.

Hartman JC, Kurc GM, Hullinger TG, Wall TM, Sheehy RM, Shebuski RJ.

J Pharmacol Exp Ther. 1994 Sep;270(3):1071-6.

PMID:
7523655

Supplemental Content

Loading ...
Support Center